Increasing prevalence of genetic disorders and chronic diseases and higher adoption of genotyping assay techniques are driving market revenue growth.
Increasing prevalence of genetic disorders and chronic diseases and higher adoption of genotyping assay techniques are driving market revenue growth
The global genotyping assay market size is expected to reach USD 87.9 Billion in 2028 and register a revenue CAGR of 22.4%, according to the latest report by Reports and Data. Increasing implementation of genotyping in drug discovery and development, and high demand for customized medicines are some key factors boosting market revenue growth.
Genotyping is a widely used technique for analyzing DNA sequence and genetic makeup by comparing with other reference sequences. Advancements in genotyping techniques are resulting in improved sequencing, operative flexibility, and access to multi-parameter testing. Technological advancements in the field of genomics, increasing research activities, and decreasing prices of DNA sequencing prices are some key factors boosting market revenue growth.
Moreover, high demand for analyzing plant and animal genomes and increasing use of genotyping assays in various fields are expected to open new revenue growth opportunities for major players operating in the global market in the years to come.
Access Free sample PDF Copy of the Report @ https://reportsanddata.com/sample-enquiry-form/4827
Some Key Highlights from the Report:
- Based on product and service, the reagents and kits segment is expected to account for substantially large revenue share over the forecast period due to growing demand for genotyping assays for research and rising number of genetic testing globally.
- On the basis of technology, the PCR segment is expected to account for significantly large revenue share throughout the forecast period. Factors such as rapid and precise detection using PCR, adoption of various PCR techniques, and introduction of novel PCR are supporting revenue growth of this segment.
- Based on application, the personalized medicine segment is expected to register robust revenue CAGR during the forecast period due to increasing government support for utilizing personalized medicines and growing implementation of genotyping assay for genetic mapping.
- The market in North America is expected to account for largest revenue share throughout the forecast period. High revenue growth is attributed to factors such as presence of well-developed healthcare centers, ongoing technological advancements in the field of genotyping assay, increasing investments by governments and private companies in research & development, growing awareness among consumers about customized medicines, and high demand for genetic testing in countries in the region.
- Europe market is expected to account for significant revenue share over the forecast period, owing to various factors including growing investments by governments and private organizations in R&D projects, and increasing cases of genetic diseases in countries in the region.
- Some major companies profiled in the market report are Thermo Fisher Scientific, Illumina, QIAGEN (Netherlands), Agilent Technologies, Danaher Corporation, Roche Diagnostics (Switzerland), GE Healthcare, Fluidigm Corporation, PerkinElmer, Eurofins Scientific (Luxembourg), Bio-Rad Laboratories, Pacific Biosciences of California, Novacyt S.A, GENEWIZ, and Integrated DNA Technologies.
Get In detailed Research Study @ https://reportsanddata.com/report-detail/genotyping-assay-market
For this study, Reports and Data has segmented the global genotyping assay market based on product and services, technology, application, end-use, and region:
Product & Service Outlook (Revenue, USD Billion, 2018 - 2028)
- Reagents & Kits
- Genotyping Services
- Instruments
- Sequencers & Amplifiers
- Analyzers
- Bioinformatics
- Software
- Services
Technology Outlook (Revenue, USD Billion, 2018 - 2028)
- PCR
- Real-time PCR
- Digital PCR
- Microarrays
- Sequencing
- NGS
- Pyrosequencing
- Sanger Sequencing
- Capillary Electrophoresis
- Amplified Fragment Length Polymorphism
- Restricted Fragment Length Polymorphism
- Single-stranded Conformation Polymorphism
- MALDI-TOF
- Other Technologies
- Allele-specific Oligonucleotide (ASO) Probes
- Fluorescence In Situ Hybridization (FISH))
Application Outlook (Revenue, USD Billion, 2018 - 2028)
- Pharmacogenomics
- Diagnostic & Personalized Medicine
- Agricultural Biotechnology
- Animal Genetics
- Other Applications
- Prenatal Testing
- Human Forensics
- Microbial Genomic Studies
- Aquaculture Breeding Studies
End-Use Outlook (Revenue, USD Billion, 2018 - 2028)
- Pharmaceutical and Biopharmaceutical Companies
- Diagnostic and Research Laboratories
- Academic Institutes
- Other End-user
- Animal and Aqua Genetics Companies
- Greenhouses
- Farms
Buy Premium Research Report @ https://reportsanddata.com/report-pricing/4827
Regional Outlook: (Revenue, USD Billion, 2018 - 2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Rest of MEA
Ask for Customize Research Report @ https://reportsanddata.com/request-customization-form/4827
Some points on how the report benefits stakeholders:
- The reports include historical (2018–2020) and forecast (2021–2028) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
- Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2018 and 2028.
- The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
- The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
- Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
- The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.
Explore Latest Trending Research Reports By Reports and Data’s
Open Surgery Heart Valves Market Size, Share And Analysis By Valve Type (Tissue and Mechanical), By Procedure Type (Open Surgery, Minimally Invasive Surgery (MIS)), By End-Use (Hospital, Clinic, and Others), and By Region Forecast to 2028
Vessel Sealing Devices Market By Product (Generators, Instruments, Accessories), By Procedure Type (Laparoscopic, Open Surgery), By Technology (LigaSure Technology, PlasmaKinetic Technology, Harmonic Scalpel, Ligamax 5 Technology, EnSeal Technology, Others), By Application, By Energy (Bipolar, Ultrasonic, Hybrid, Others), By End-use, and By Region, Forecast to 2028
Atropine Market , By Product Type (Injection, Drop, Gel), By Application (Gastrointestinal, Ophthalmology, Others), and By Region Forecast to 2028
Tinea Pedis Treatment Market , By Disease Type (Interdigital Tinea Pedis, Plantar Tinea Pedis, Vesicular Tinea Pedis), By Route of Administration (Oral and Topical [Gel, Creams, Spray, Lotions, and Powders]), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and E-Commerce), and By Region Forecast to 2028
Respiratory Inhaler Devices Market Size, Share & Analysis, By Product Type (Dry Powder Inhaler, Metered Dose Inhaler, Nebulizer), By Mode of Operation (Digitally Operated Inhaler Devices), By Application (Chronic Obstructive Pulmonary Disease, Asthma), And By Region, Forecast To 2027
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read Latest Press Release @ https://reportsanddata.com/press-release/global-genotyping-assay-market